146 related articles for article (PubMed ID: 9491850)
1. Tumor necrosis factor beta is a major source of antibody-activated effector cells in the killing of virally infected target cells.
Choi SH; Kim CW
Pathobiology; 1997; 65(6):301-10. PubMed ID: 9491850
[TBL] [Abstract][Full Text] [Related]
2. Induction of MHC-unrestricted cytolytic CD4+ T cells against virally infected target cells by cross-linking CD4 molecules.
Choi SH; Splitter GA
J Immunol; 1994 Nov; 153(9):3874-81. PubMed ID: 7930600
[TBL] [Abstract][Full Text] [Related]
3. Contribution of tyrosine kinases to the selective orientation of human CD4+ bifunctional cloned T cells toward proliferation or cytolytic function.
Eljaafari A; Soula M; Dorval I; Pirenne H; Quelvennec E; Bernard A; Fagard R; Sterkers G
J Immunol; 1994 Nov; 153(9):3882-9. PubMed ID: 7930601
[TBL] [Abstract][Full Text] [Related]
4. Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56lck.
Li Y; Yio XY; Mayer L
J Exp Med; 1995 Oct; 182(4):1079-88. PubMed ID: 7561681
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein tyrosine kinases or protein kinase C prevents nonspecific killer T lymphocyte-mediated tumoricidal activity.
Stewart BH; Hoskin DW
Biochim Biophys Acta; 1997 May; 1356(3):333-42. PubMed ID: 9194576
[TBL] [Abstract][Full Text] [Related]
6. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine kinase p56lck regulates TCR expression and T cell selection.
Ericsson PO; Teh HS
Int Immunol; 1995 Apr; 7(4):617-24. PubMed ID: 7547689
[TBL] [Abstract][Full Text] [Related]
8. Association of the p56lck protein tyrosine kinase with the Fc gamma RIIIA/CD16 complex in human natural killer cells.
Cone JC; Lu Y; Trevillyan JM; Bjorndahl JM; Phillips CA
Eur J Immunol; 1993 Oct; 23(10):2488-97. PubMed ID: 8405050
[TBL] [Abstract][Full Text] [Related]
9. The Ick protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HIV-1 transcription.
Coudronnière N; Corbeil J; Robert-Hebmann V; Mesnard JM; Devaux C
Eur J Immunol; 1998 May; 28(5):1445-57. PubMed ID: 9603449
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
[TBL] [Abstract][Full Text] [Related]
11. The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration.
Ryan TC; Cruikshank WW; Kornfeld H; Collins TL; Center DM
J Biol Chem; 1995 Jul; 270(29):17081-6. PubMed ID: 7615501
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-induced activation of tilapia nonspecific cytotoxic cells by serum cytokines.
Ruiz J; Leary JH; Jaso-Friedmann L
Dis Aquat Organ; 2001 Sep; 46(2):129-37. PubMed ID: 11678228
[TBL] [Abstract][Full Text] [Related]
13. Two distinct mechanisms of cytotoxicity mediated by herpes simplex virus-specific CD4+ human cytotoxic T cell clones.
Yasukawa M; Yakushijin Y; Fujita S
Clin Immunol Immunopathol; 1996 Jan; 78(1):70-6. PubMed ID: 8599887
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan.
Dong ZM; Jackson L; Murphy JW
Infect Immun; 1999 Jan; 67(1):220-9. PubMed ID: 9864219
[TBL] [Abstract][Full Text] [Related]
15. Analysis of recombinant human tumour necrosis factor-alpha-induced CD4 expression on human eosinophils.
Hossain M; Okubo Y; Horie S; Sekiguchi M
Immunology; 1996 Jun; 88(2):301-7. PubMed ID: 8690465
[TBL] [Abstract][Full Text] [Related]
16. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
17. CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses.
Ohnishi H; Ledbetter JA; Kanner SB; Linsley PS; Tanaka T; Geller AM; Kotb M
J Immunol; 1995 Apr; 154(7):3180-93. PubMed ID: 7534790
[TBL] [Abstract][Full Text] [Related]
18. GF109203X, a specific PKC inhibitor, abrogates anti-CD3 antibody-induced upregulation of CD4+ T cell adhesion to B cells.
Hauss P; Mazerolles F; Hivroz C; Lecomte O; Barbat C; Fischer A
Cell Immunol; 1993 Sep; 150(2):439-46. PubMed ID: 8103710
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.
Anel A; Buferne M; Boyer C; Schmitt-Verhulst AM; Golstein P
Eur J Immunol; 1994 Oct; 24(10):2469-76. PubMed ID: 7523141
[TBL] [Abstract][Full Text] [Related]
20. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
